Navigation Links
FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis
Date:3/11/2010

WAYNE, N.J., March 11 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals announced today that an orphan drug designation has been granted by the U.S. Food and Drug Administration (FDA) for ciprofloxacin dry powder inhaler (DPI) for management of pulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis (CF) patients. A similar designation has already been granted by the European Medicines Agency. Ciprofloxacin DPI is an investigational drug–device combination that combines ciprofloxacin dry powder formulated using Novartis' Proprietary PulmoSphere® technology with a delivery inhaler. Ciprofloxacin DPI is in Phase II development and is being studied for its safety and potential to improve lung function, as measured by the forced expiratory volume in 1 second (FEV1), in patients with CF.

"There continue to be significant unmet medical needs for people with cystic fibrosis," said Shannon Campbell, Vice President and General Manager, Oncology and General Medicine, Bayer HealthCare Pharmaceuticals.  "We are pleased to receive the orphan drug designation from the FDA for ciprofloxacin DPI, which we are researching as a potential treatment option for management of pulmonary infections due to P. aeruginosa in CF patients."

Cystic fibrosis is a life-threatening inherited disease affecting the lungs, pancreas, liver, and intestines(1). Approximately 30,000 patients in the US are affected by CF(1). In 2008, the median a
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025
2. Hospira Supports Disaster Relief Efforts in Haiti With Products and Cash Grants
3. Chiasma Grants Option to License Transient Permeability Enhancer (TPE) Technology for Small Molecule Products
4. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
5. European Medicines Agency Grants Cell Therapeutics Orphan Drug Designation for Pixantrone in Diffuse Large B-Cell Lymphoma (DLBCL)
6. Pfenex Grants Exclusive License to Merck & Co., Inc. for the Production of Proteins for Undisclosed Vaccine Program
7. FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology
8. SRI International Receives National Institutes of Health Grants to Develop Improved Tomographic Imaging Technology
9. The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies
10. U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine)
11. FDA Grants GeoVax Labs, Inc. Request For Pre-IND Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013 Sinovac Biotech Ltd. ... in China , today announced that it ... ended March 31, 2013, before market on Tuesday, May 28, ... May 28, 2013, at 8:00 a.m. EDT (May 28, 2013 ... financial results and provide an update on recent corporate developments. ...
(Date:5/16/2013)... , May 16, 2013  PTC Therapeutics, Inc., ... on Form S-1 with the U.S. Securities and Exchange ... of its common stock. The number of shares to ... have not been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ... are acting as joint book-running managers for the offering. ...
(Date:5/16/2013)... Inc. (NYSE: ALR ), a global leader in ... through the merger of rapid diagnostics and health management, has ... Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B).  The dividend ... of Series B stock at the close of business on ... amount of all dividends accrued from April 1, 2013 through ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... 2011 NxStage® Medical, Inc. (Nasdaq: NXTM ... announced that its Chief Executive Officer, Jeffrey H. Burbank, ... Voice of New England Innovation, 2011 All-Stars Awards. The ... New England,s innovation economy. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO) ...
... Ventana Medical Systems , Inc., (Ventana) a member of the Roche ... efficiency and throughput in today,s anatomic pathology laboratories. The new product ... annual meeting on Sept. 11, 2011, at 12:12 ... The real promise associated with the transition to ...
Cached Medicine Technology:NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award 2NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award 3NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award 4Innovative Digital Pathology Solutions to be Unveiled at CAP '11 2
(Date:5/20/2013)... Chicago, IL (PRWEB) May 20, 2013 iGearUnlimited.com ... of an iPad case for students. The answers didn't surprise ... iPad from daily use and abuse, 2. Not too bulky ... and kids' backpack, 3. Built-in kick-stand that works in both ... need show as a trackable barcodes on each case, 5. ...
(Date:5/20/2013)... May 20, 2013 Milpitas, Los ... industry leader in enterprise-class information archiving, eDiscovery and ... Platform 7.0, the latest release in the MessageSolution ... of the legal discovery lifecycle. MessageSolution will exhibit ... Angeles CA. , As the first stop of ...
(Date:5/20/2013)... Can you tell a joke well? , Do ... , Would you like to be funnier as a speaker, teacher, ... funny bone is missing? , Can't think of a snappy comeback ... If this sounds like you, don't worry. Help is here. ... of humor; and even learn to tell a joke well. I ...
(Date:5/20/2013)... Olympia, WA (PRWEB) May 20, 2013 ... privacy solutions, today announced that the company’s Alliance ... TrueCrypt password management with Key Connection for ... and use cryptographically strong passwords when using TrueCrypt ... first company to offer secure password management for ...
(Date:5/19/2013)... Ga (PRWEB) May 20, 2013 California has ... country – and employers are quickly discovering that comprehensive background ... candidate for a job. Driving records can ... help reveal if that person has any DUI arrests, speeding ... more California employers are lining up to experience 4SafeDrivers.com, a ...
Breaking Medicine News(10 mins):Health News:New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments 2Health News:New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 2Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 4Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 2Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 3Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 4Health News:Alliance Key Manager, Townsend Security’s FIPS 140-2 Compliant Encryption Key Manager Now Includes Support for Managing TrueCrypt Passwords 2Health News:Alliance Key Manager, Townsend Security’s FIPS 140-2 Compliant Encryption Key Manager Now Includes Support for Managing TrueCrypt Passwords 3Health News:4SafeDrivers.com Announces Driving Record Searches for California Employers 2
... 30, 2009 at the Healthcare Travel Congress in Singapore. This is the ... an online platform to market their products and services. , ... Bangkok, ... search portal founded by medical tourism pioneer Ruben Toral, has formed ...
... acid, or vitamin B9, essential for red blood cell health ... defects, may also suppress allergic reactions and lessen the severity ... the Johns Hopkins Children,s Center. , In what is ... link between blood levels of folate the naturally occurring ...
... Generates Record $94 Million in Total Revenues for the QuarterSAN DIEGO, ... BMR ), a real estate investment trust focused on ... and financial results for the first quarter ended March 31, 2009. ... Record total revenues for the first quarter ...
... 29 /PRNewswire/ -- Traumatic brain ... brain,s structure, is common among Veterans and has been ... VA,s research related to TBI is wide-ranging. Among its ... condition; improving methods of screening and diagnosis; developing drugs ...
... chances of a relapse or a deterioration of the condition, according ... London. , The results of a major trial presented at the ... that taking a course of cladribine tablets just a few times ... over 50 per cent. And patients who took part in the ...
... ground on a revitalization project for the communityDEARBORN, Mich., ... representatives from Midwest Health Center, the City of Dearborn ... Dearborn Town Center development project - a mixed use ... space and an assisted living facility for seniors located ...
Cached Medicine News:Health News:Medeguide Announces Online Marketing Partnership with Admax Plus to Promote Doctors and Treatment Packages Online 2Health News:Medeguide Announces Online Marketing Partnership with Admax Plus to Promote Doctors and Treatment Packages Online 3Health News:Hopkins Children's study: Folic acid may help treat allergies, asthma 2Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 2Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 3Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 4Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 5Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 6Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 7Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 8Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 9Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 10Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 11Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 12Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 13Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 14Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 15Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 16Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 17Health News:Video: Turning Hope Into Reality - Traumatic Brain Injury Research at the VA 2Health News:New pill to treat MS 2Health News:Oakwood Investment Triggers the Development of a New Landmark in Downtown East Dearborn 2
Inquire...
... The Genesis RMP is ideal for hospital ... for reference and pharmaceutical laboratories. It fully ... ELISA and EIA assays from different manufacturers. ... throughput of up to 600'000 tests, using ...
Qualitative EIA for SS-A, SS-B, Sm, Sm/RNP plus Scl-70 and Jo-1...
... Automation, Inc. (DAI) ENA Profile Enzyme-Linked Immunosorbent ... of antibodies in human serum to individually ... Scl-70 and Jo-1 in a single serum ... to be used as an aid in ...
Medicine Products: